文献速递衰弱、肌少症与跌倒老年慢病共病管理

荷兰COVID-19住院老年患者第一波与第二波疫情特征及结局比较:COVID-OLD研究

Characteristics and outcomes of older patients hospitalised for COVID-19 in the first and second wave of the pandemic in The Netherlands: the COVID-OLD study.
PubMed 文献 · Age Ageing · 2022-01-01

该多中心回顾性队列纳入荷兰16家医院≥70岁COVID-19住院患者,第一波1376例、第二波946例。两波合并症与衰弱程度无相关差异,第二波患者入院更早、住院死亡率更低,校正多种因素后第二波死亡风险较第一波低40%。

要点

  • 第二波患者住院死亡率为27.0%,低于第一波的38.1%。
  • 校正患者特征、合并症、入院前症状天数、疾病严重度及衰弱后,第二波死亡风险低40%(95%CI 28-51%)。
  • 两波合并症负担(中位CCI 2)与衰弱(中位CFS 4)无相关差异。

核心结论

  • 与第一波相比,第二波住院老年COVID-19患者住院死亡率更低,且独立于死亡危险因素。
  • 预后改善可能反映更早诊断与治疗改进,对今后指南和治疗决策有参考意义。

研究设计与样本

  • 荷兰16家医院的多中心回顾性队列研究,纳入≥70岁COVID-19住院患者。
  • 第一波为2020年春季,第二波为2020年秋季;收集CCI、疾病严重度和CFS,主要结局为住院死亡率。

主要发现

  • 第一波1376例,中位年龄78岁,男性60%;第二波946例,中位年龄79岁,男性61%。
  • 两波合并症(中位CCI 2)与衰弱(中位CFS 4)无相关差异。
  • 第二波入院更早(中位症状天数6天对7天;P<0.001)。
  • 住院死亡率第二波27.0%,第一波38.1%(P<0.001)。
  • 校正患者特征、合并症、入院前症状天数、疾病严重度和衰弱后,第二波死亡风险低40%(95%CI 28-51%)。

关键数值与推荐

  • 住院死亡率:第一波38.1%,第二波27.0%(P<0.001)。
  • 校正后第二波死亡风险较第一波低40%(95%CI 28-51%)。
  • 入院前中位症状天数:第二波6天,第一波7天(P<0.001)。
  • 合并症中位CCI为2,衰弱中位CFS为4,两波无相关差异。

临床怎么用

  • 对住院老年COVID-19患者进行合并症与衰弱评估,有助风险分层与治疗决策。
  • 早期诊断与及时入院可能改善老年患者预后,应关注就诊延迟问题。
  • 不同疫情波次结局存在差异,解读历史数据与制定指南时需考虑时间因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: as the coronavirus disease of 2019 (COVID-19) pandemic progressed diagnostics and treatment changed. OBJECTIVE: to investigate differences in characteristics, disease presentation and outcomes of older hospitalised COVID-19 patients between the first and second pandemic wave in The Netherlands. METHODS: this was a multicentre retrospective cohort study in 16 hospitals in The Netherlands including patients aged ≥ 70 years, hospitalised for COVID-19 in Spring 2020 (first wave) and Autumn 2020 (second wave). Data included Charlson comorbidity index (CCI), disease severity and Clinical Frailty Scale (CFS). Main outcome was in-hospital mortality. RESULTS: a total of 1,376 patients in the first wave (median age 78 years, 60% male) and 946 patients in the second wave (median age 79 years, 61% male) were included. There was no relevant difference in presence of comorbidity (median CCI 2) or frailty (median CFS 4). Patients in the second wave were admitted earlier in the disease course (median 6 versus 7 symptomatic days; P < 0.001). In-hospital mortality was lower in the second wave (38.1% first wave versus 27.0% second wave; P < 0.001). Mortality risk was 40% lower in the second wave compared with the first wave (95% confidence interval: 28-51%) after adjustment for differences in patient characteristics, comorbidity, symptomatic days until admission, disease severity and frailty. CONCLUSIONS: compared with older patients hospitalised in the first COVID-19 wave, patients in the second wave had lower in-hospital mortality, independent of risk factors for mortality.The better prognosis likely reflects earlier diagnosis, the effect of improvement in treatment and is relevant for future guidelines and treatment decisions.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Smits RAL, Trompet S, van der Linden CMJ, et al. Characteristics and outcomes of older patients hospitalised for COVID-19 in the first and second wave of the pandemic in The Netherlands: the COVID-OLD study. Age Ageing. 2022. PMID: 35235650. doi:10.1093/ageing/afac048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。